$FHTX 4 SEC Filings

Filed On	Filing
25 Jun 2026	Form 4: Duty Stuart, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Biller Scott, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Gallagher Neil, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Mendelsohn Michael, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Smith Ian F, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Gill Simba, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Parshall B Lynne, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Cole Douglas G., Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Lynch Thomas J. Jr., Director Granted 28,000 Stock Options (Right to buy) ($114K)
13 Apr 2026	Form 4: Gottschalk Adrian, Director Gave 47,497 shares as a gift · Acquired 47,497 shares (Gift) · Gave 59,208 shares as a gift · 1 more
24 Feb 2026	Form 4: Maynard Ryan D, Chief Financial Officer Granted 400,000 Stock Option (right to buy) ($2.3M)
06 Feb 2026	Form 4: Gottschalk Adrian, Director Granted 1,075,000 Stock option (right to buy) ($5.62M)
02 Feb 2026	Form 4: Costa Carlos, Chief People Officer Granted 230,000 Stock option (right to buy) ($1.31M)
02 Feb 2026	Form 4: LaCascia Michael, Chief Legal Officer Granted 295,000 Stock option (right to buy) ($1.68M)
02 Feb 2026	Form 4: Cardama Alfonso Quintas, Chief Medical Officer Granted 300,000 Stock option (right to buy) ($1.71M)
02 Feb 2026	Form 4: Rivkin Anna, Chief Business Officer Granted 165,000 Stock option (right to buy) ($942K)
02 Feb 2026	Form 4: Bellon Steven F., Chief Scientific Officer Granted 300,000 Stock Option (right to buy) ($1.71M)
15 Jan 2026	Form 4: Flagship Pioneering, Llc, Director and 9 others Granted 2,235,468 Pre-Funded Warrants to purchase Common Stock ($15M) · Granted 1,117,734 Series 1 Warrants to purchase Common Stock · Granted 1,117,734 Series 2 Warrants to purchase Common Stock
17 Nov 2025	Form 4: Humer Kristian, Chief Financial Officer
17 Jun 2025	Form 4: Biller Scott, Director Granted 25,000 Stock Option (right to buy) ($120K)

Comments